Compare surgery with/without chemo

Home

Age (70 - 99)

Note: For patients over 80 the results are less reliable.

Tumour grade

123

Tumour size

Disease nodes positive

None1 to 34+

ER status

NegativePositive

HER2 status

NegativePositive

Comorbidities - Tick all that apply

AIDS COPD Cerebrovascular Disease Congestive Heart Failure Connective Tissue Disease Dementia Diabetes Mellitus (no complications) Diabetes Mellitus (with organ damage) Hemiplegia

Liver Disease (mild) Liver Disease (moderate/severe) Moderate/Severe Renal Disease Myocardial Infarction Other cancer (metastatic) Peptic Ulcer Disease Peripheral Vascular Disease Previous/concurrent cancer (non-metastatic)

Frailty - Activity of Daily Living (ADL)

Please enter a score for each dimension below (0 = No difficulty, 1 = Some difficulty, 2 = A lot of difficulty, 3 = Unable) and the ADL Stage will be calculated automatically.

Difficulty eating

0123

Difficulty getting to and using the toilet

0123

Difficulty dressing

0123

Difficulty transferring (to and from chair/bed)

0123

Difficulty bathing

0123

Difficulty walking

0123

Enter the patient's details above and click the button:

If you need to collect the information in stages you can download a paper form and fill in the online form at a later date.

The Age Gap Decision Tool is a software medical device that provides reference information to help a Healthcare Professional to use their knowledge to make a clinical decision.

Version 1.0
Built by epiGenesys

Please Note: The Age Gap on line tool uses a mathematic model based on information from many thousands of women over the age of 70 years diagnosed with early breast cancer between 2002 and 2012. Data was obtained using the UK cancer registration service. Outcomes are predicted based on the actual outcomes of these women. The model was developed on one set of data from the West Midlands and Northern and Yorkshire regions which has been subjected to peer review and published and has been validated on a second dataset to enhance accuracy and reliability. Despite this, as with any mathematical model, it may be inaccurate for an individual woman and can only provide an estimate of likely outcomes. The tool is designed to be used in consultation with an expert clinician and take into account a wide range of parameters and in collaboration with the patient and her preferences and opinions.